Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.1 USD | -1.11% | -1.18% | -29.93% |
Mar. 13 | Teladoc Health Seeks M&A | CI |
Mar. 13 | Transcript : Teladoc Health, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:30 AM |
Financials (USD)
Sales 2024 * | 2.67B | Sales 2025 * | 2.77B | Capitalization | 2.52B |
---|---|---|---|---|---|
Net income 2024 * | -175M | Net income 2025 * | -117M | EV / Sales 2024 * | 1.05 x |
Net Debt 2024 * | 278M | Net Debt 2025 * | 167M | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
-14.2
x | P/E ratio 2025 * |
-22.4
x | Employees | 5,208 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.21% |
Latest transcript on Teladoc Health, Inc.
1 day | -1.11% | ||
1 week | -1.18% | ||
Current month | +0.13% | ||
1 month | +0.07% | ||
3 months | -31.67% | ||
6 months | -18.51% | ||
Current year | -29.93% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Gorevic
CEO | Chief Executive Officer | 52 | 09-05-31 |
Mala Murthy
DFI | Director of Finance/CFO | 60 | 19-06-23 |
Jeff Nadler
CTO | Chief Tech/Sci/R&D Officer | - | 11-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Snow
CHM | Chairman | 69 | 14-01-31 |
Sandra Fenwick
BRD | Director/Board Member | 73 | 20-11-18 |
David Shedlarz
BRD | Director/Board Member | 74 | 16-09-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.31% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 15.1 | -1.11% | 2,488,118 |
24-03-27 | 15.27 | +1.46% | 3,541,699 |
24-03-26 | 15.05 | -0.20% | 3,060,099 |
24-03-25 | 15.08 | +0.53% | 2,958,062 |
24-03-22 | 15 | -1.83% | 2,889,567 |
Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.93% | 2.52B | |
+73.82% | 3.31B | |
+40.55% | 603M | |
+42.77% | 470M | |
-45.59% | 234M | |
-21.58% | 99.19M |